-
15776-500A broad-spectrum, first-generation cephalosporin antibiotic that inhibits bacterial cell wall synthesis, causing growth to cease without lysis.
-
17176-10A third generation cephalosporin antibiotic that is effective against a variety of Gram-negative bacteria, including E. coli, K. pneumoniae, and H. influenzae (MIC values range from <0.025 to 25 µg/ml).
-
18745-1A broad-spectrum antibiotic with a prolonged serum elimination half-life in animals.
-
18745-100A broad-spectrum antibiotic with a prolonged serum elimination half-life in animals.
-
18745-500A broad-spectrum antibiotic with a prolonged serum elimination half-life in animals.
-
16113-1A cephalosporin antibiotic that is active in vitro against most Gram-positive and Gram-negative bacteria, including &beta-lactamase strains (3-4 µg/ml inhibits 90% of S. aureus growth).
-
16113-10A cephalosporin antibiotic that is active in vitro against most Gram-positive and Gram-negative bacteria, including &beta-lactamase strains (3-4 µg/ml inhibits 90% of S. aureus growth).
-
16113-5A cephalosporin antibiotic that is active in vitro against most Gram-positive and Gram-negative bacteria, including &beta-lactamase strains (3-4 µg/ml inhibits 90% of S. aureus growth).
-
16040-1A cephalosporin antibiotic with potent in vitro activity against streptococcal species, including S. aureus (IC<sub>50</sub> = 2 µg/ml) and penicillin-resistant S.
-
16040-250A cephalosporin antibiotic with potent in vitro activity against streptococcal species, including S. aureus (IC<sub>50</sub> = 2 µg/ml) and penicillin-resistant S.
-
16040-5A cephalosporin antibiotic with potent in vitro activity against streptococcal species, including S. aureus (IC<sub>50</sub> = 2 µg/ml) and penicillin-resistant S.
-
16040-500A cephalosporin antibiotic with potent in vitro activity against streptococcal species, including S. aureus (IC<sub>50</sub> = 2 µg/ml) and penicillin-resistant S.